We are live on ! Find out more
NUTX

Nutex Health

41 hedge funds and large institutions have $28.7M invested in Nutex Health in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

184% more capital invested

Capital invested by funds: $10.1M → $28.7M (+$18.6M)

37% more funds holding

Funds holding: 3041 (+11)

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

7.67% more ownership

Funds ownership: 8.99%16.67% (+7.7%)

Holders
41
Holders Change
+11
Holders Change %
+36.67%
% of All Funds
0.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
10
Reduced
8
Closed
5
Calls
Puts
Net Calls
Net Calls Change

NUTX Hedge Fund Activity: Q4 2024 in Review

41 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q4 2024, worth a combined $28.7M — up 184% from $10.1M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new NUTX positions and 5 closed out — a net gain of 11 holders — while 10 added to existing stakes and 8 trimmed.

The largest buyer was American Century Companies, opening a new position worth an estimated $1.23M. The largest seller was Marshall Wace, cutting an estimated $865K.

  • 41 institutional investors held Nutex Health (NUTX) as of Q4 2024, up from 30 in Q3 2024.
  • Funds reported $28.7M of Nutex Health stock for Q4 2024, up 184% quarter-over-quarter.
  • 16 funds opened new Nutex Health positions in Q4 2024 and 5 closed out, a net change of +11 holders.
  • The largest Nutex Health buyer in Q4 2024 was American Century Companies, an estimated $1.23M added.
  • The largest Nutex Health seller in Q4 2024 was Marshall Wace, an estimated $865K sold.

Based on aggregated 13F filings for Q4 2024.